O
AVNS

OppenheimerFunds’s Avanos Medical AVNS Stock Holding History

OppenheimerFunds’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-6,674
Closed -$458K – 1798
2018
Q3 		$458K Sell
6,674
-5,153
-44% -$332K ﹤0.01% 1489
2018
Q2 		$677K Sell
11,827
-4,190
-26% -$221K ﹤0.01% 1294
2018
Q1 		$738K Sell
16,017
-3,508
-18% -$167K ﹤0.01% 1207
2017
Q4 		$902K Sell
19,525
-1,453
-7% -$66.8K ﹤0.01% 1214
2017
Q3 		$945K Sell
20,978
-2,696
-11% -$115K ﹤0.01% 1208
2017
Q2 		$930K Sell
23,674
-222
-0.9% -$8.39K ﹤0.01% 1206
2017
Q1 		$910K Buy
23,896
+3,947
+20% +$154K ﹤0.01% 1205
2016
Q4 		$737K Buy
19,949
+6,958
+54% +$249K ﹤0.01% 1199
2016
Q3 		$450K Buy
12,991
+2,921
+29% +$102K ﹤0.01% 1309
2016
Q2 		$327K Sell
10,070
-375
-4% -$11.5K ﹤0.01% 1422
2016
Q1 		$300K Sell
10,445
-1,113
-10% -$29.7K ﹤0.01% 1451
2015
Q4 		$386K Buy
+11,558
New +$359K ﹤0.01% 1399

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OppenheimerFunds's AVNS Position: Q4 2018 in Review

OppenheimerFunds sold out of Avanos Medical (AVNS) in Q4 2018, closing a stake of 6,674 shares — an estimated $458K sold.

OppenheimerFunds first reported a position in AVNS in Q4 2015 and held it in 12 quarters. The position peaked at $945K in Q3 2017. 350 funds tracked by Wall St. Rank hold AVNS as of Q4 2018.

  • OppenheimerFunds reported no remaining Avanos Medical position as of Q4 2018 after selling out during the quarter.
  • OppenheimerFunds sold 6,674 Avanos Medical shares in Q4 2018, an estimated $458K.
  • OppenheimerFunds first reported a position in Avanos Medical in Q4 2015 and held it in 12 quarters.
  • OppenheimerFunds's Avanos Medical position peaked at $945K in Q3 2017.
  • 350 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2018.

Based on OppenheimerFunds's 13F filing for Q4 2018, filed 11 Feb 2019.